Strat-M® positioning for skin permeation studies: A comparative study including EpiSkin® RHE, and human skin - Université de Tours Accéder directement au contenu
Article Dans Une Revue International Journal of Pharmaceutics Année : 2023

Strat-M® positioning for skin permeation studies: A comparative study including EpiSkin® RHE, and human skin

Résumé

In the development and optimization of dermatological products, In Vitro Permeation Testing (IVPT) is pivotal for controlled study of skin penetration. To enhance standardization and replicate human skin properties reconstructed human skin and synthetic membranes are explored as alternatives. Strat-M® is a membrane designed to mimic the multi-layered structure of human skin for IVPT. For instance, in Strat-M®, the steady-state fluxes (JSS) of resorcinol in formulations free of permeation enhancers were found to be 41 ± 5 μg/cm2⋅h for the aqueous solution, 42 ± 6 μg/cm2⋅h for the hydrogel, and 40 ± 6 μg/cm2⋅h for the oil-in-water emulsion. These results were closer to excised human skin (5 ± 3, 9 ± 2, 13 ± 6 μg/cm2⋅h) and surpassed the performance of EpiSkin® RHE (138 ± 5, 142 ± 6, and 162 ± 11 μg/cm2⋅h). While mass spectrometry and Raman microscopy demonstrated the qualitative molecular similarity of EpiSkin® RHE to human skin, it was the porous and hydrophobic polymer nature of Strat-M® that more faithfully reproduced the skin’s diffusion-limiting barrier. Further validation through similarity factor analysis (~80–85%) underscored Strat-M®’s significance as a reliable substitute for human skin, offering a promising approach to enhance realism and reproducibility in dermatological product development.
Fichier non déposé

Dates et versions

hal-04249883 , version 1 (19-10-2023)

Identifiants

Citer

Hichem Kichou, Franck Bonnier, Yuri Dancik, Joudi Bakar, Rime Michael-Jubeli, et al.. Strat-M® positioning for skin permeation studies: A comparative study including EpiSkin® RHE, and human skin. International Journal of Pharmaceutics, 2023, 647, pp.123488. ⟨10.1016/j.ijpharm.2023.123488⟩. ⟨hal-04249883⟩
27 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More